Equillium, Inc. (EQ)
NASDAQ: EQ · IEX Real-Time Price · USD
2.310
+0.250 (12.14%)
At close: Mar 28, 2024, 4:00 PM
2.340
+0.030 (1.30%)
After-hours: Mar 28, 2024, 6:26 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $72.35 million as of March 28, 2024. Its market cap has increased by 218.70% in one year.
Market Cap
72.35M
Enterprise Value
32.30M
1-Year Change
218.70%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $233.80M to $72.35M, a decrease of -69.06%. That is a compound annual growth rate of -19.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 72.60M | - |
Mar 26, 2024 | 72.60M | -15.58% |
Mar 25, 2024 | 86.00M | -13.13% |
Mar 22, 2024 | 99.00M | 1.75% |
Mar 21, 2024 | 97.30M | -3.76% |
Mar 20, 2024 | 101.10M | 6.98% |
Mar 19, 2024 | 94.50M | 1.94% |
Mar 18, 2024 | 92.70M | 3.92% |
Mar 15, 2024 | 89.20M | -0.45% |
Mar 14, 2024 | 89.60M | -3.03% |
Mar 13, 2024 | 92.40M | 3.94% |
Mar 12, 2024 | 88.90M | - |
Mar 11, 2024 | 88.90M | -5.22% |
Mar 8, 2024 | 93.80M | -1.47% |
Mar 7, 2024 | 95.20M | 19.90% |
Mar 6, 2024 | 79.40M | 0.89% |
Mar 5, 2024 | 78.70M | 0.51% |
Mar 4, 2024 | 78.30M | -10.82% |
Mar 1, 2024 | 87.80M | 0.46% |
Feb 29, 2024 | 87.40M | -4.27% |
Feb 28, 2024 | 91.30M | 3.99% |
Feb 27, 2024 | 87.80M | -10.04% |
Feb 26, 2024 | 97.60M | 9.42% |
Feb 23, 2024 | 89.20M | -2.30% |
Feb 22, 2024 | 91.30M | 3.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chimerix | 87.83M |
PMV Pharmaceuticals | 87.71M |
111, Inc. | 87.35M |
BioXcel Therapeutics | 87.14M |
Corvus Pharmaceuticals | 86.31M |
Rezolute | 84.01M |
Aclaris Therapeutics | 83.69M |
Cue Biopharma | 83.03M |